close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

578.71 -1.42 (-0.24%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
30 31 Next >
News headline image
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever. ↗
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
News headline image
You’ve Been Warned! 3 Nanotech Stocks to Buy Now or Regret Forever ↗
Nanotech stocks are seeing robust support from U.S. legislation, with leaders offering promising upside amid significant projections. 
Via InvestorPlace
News headline image
What the Options Market Tells Us About Thermo Fisher Scientific ↗
 
Via Benzinga
News headline image
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty ↗
Catalent shares rise after Sarepta Therapeutics' Elevidys expanded approval. Despite uncertainties, Catalent's risk/reward profile improves. 
Via Benzinga
News headline image
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
This Is What Whales Are Betting On Thermo Fisher Scientific ↗
 
Via Benzinga
News headline image
P/E Ratio Insights for Thermo Fisher Scientific ↗
 
Via Benzinga
News headline image
$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?
The fastest-growing dividends in the S&P 500 are good buys, but that doesn't mean it's time to buy them now; only one is accelerating distribution growth. 
Via MarketBeat
Topics Stocks
News headline image
Morgan Stanley Fund Manager Advises Investors To Diversify Amid Big Tech Frenzy: Here Are 2 Stocks He Recommends ↗
Aaron Dunn, a portfolio manager at Morgan Stanley, advised investors to diversify beyond the "Magnificent Seven" tech stocks. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific's Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
Analyst Scoreboard: 10 Ratings For Thermo Fisher Scientific ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Thermo Fisher Scientific? ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Releases 2023 Corporate Social Responsibility Report
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
News headline image
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Declares Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells ↗
The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken without her consent in the 1950s. A Maryland federal court ruled against... 
Via Benzinga
Topics Lawsuit
News headline image
3 Biotech Stocks to Buy Now: May 2024 ↗
As the biotech industry continues to rise in market prominence, investors should start considering what the best biotech stocks to buy are. 
Via InvestorPlace
News headline image
Healthcare And Biotech Investing 101: What You Need To Know. ↗
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of... 
Via Talk Markets
Topics Stocks
News headline image
7 Robotics Stocks to Bet On for Reliable AI-Powered Returns ↗
Investors know that robotics stocks to buy are a smart investment as AI continues to change the labor force and economy in 2024 and beyond. 
Via InvestorPlace
Topics Artificial Intelligence Economy
News headline image
Thermo Fisher Scientific to Present at BofA Securities 2024 Health Care Conference on May 14
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
From Thermo Fisher Scientific Inc.
Via Business Wire
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today